Ghaleb Elyamany

Central venous access in oncology: ESMO Clinical Practice Guidelines

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Targeting apoptosis in cancer therapy

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL

Concomitant high expression of Toll‐like receptor (TLR) and B‐cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma

Cancer-Associated Thrombosis: An Overview